Skip to main content
Signal8

Kenney Richard T

SEC insider (Form 3/4/5 filer). CIK 0001606653. Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. (SONN). 11 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2025. Located in PRINCETON,, NJ.

Companies Kenney Richard T has filed insider reports for

  • Sonnet BioTherapeutics Holdings, Inc. (SONN): Officer, Chief Medical Officer
Kenney Richard T profile photo

Kenney Richard T

CIK: 0001606653

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (18.2%)

Derivative conversions

Awards (A)5 (45.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (36.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sonnet BioTherapeutics Holdings, Inc. logo
SONN

Sonnet BioTherapeutics Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Disposition
    Direct
    163.8K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Disposition
    Direct
    9.4K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Exercise
    Direct
    86.5K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Tax Payment
    Direct
    16.9K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Disposition
    Direct
    69.6K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Exercise
    Direct
    163.8K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jul 14, 2025
    Award

    Series 5 Preferred Stock

    Direct
    200 shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jul 14, 2025
    Award

    Warrant

    Direct
    320K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jul 11, 2025
    Award
    Direct
    8K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jun 30, 2025
    Award

    Warrant

    Direct
    86.5K shares-

1-10 of 11